- Home
- Publications
- Publication Search
- Publication Details
Title
Implications of Heterogeneity in Multiple Myeloma
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2014-07-03
DOI
10.1155/2014/232546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival
- (2015) Renji Reghunathan et al. Oncotarget
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- RAR 2 expression confers myeloma stem cell features
- (2013) Y. Yang et al. BLOOD
- Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
- (2013) G. Mulligan et al. BLOOD
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
- (2013) B Hebraud et al. LEUKEMIA
- Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
- (2013) B A Walker et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma
- (2013) Tae-Hoon Chung et al. PLoS One
- Targeting the BRAF V600E Mutation in Multiple Myeloma
- (2013) M. Andrulis et al. Cancer Discovery
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells
- (2012) David Chiron et al. BLOOD CELLS MOLECULES AND DISEASES
- Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow
- (2012) K. Boucher et al. CLINICAL CANCER RESEARCH
- Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
- (2012) B. E. Swift et al. HAEMATOLOGICA
- Long-Term Analysis of the IFM 99 Trials for Myeloma: Cytogenetic Abnormalities [t(4;14), del(17p), 1q gains] Play a Major Role in Defining Long-Term Survival
- (2012) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- A gene expression signature for high-risk multiple myeloma
- (2012) R Kuiper et al. LEUKEMIA
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma
- (2012) Alboukadel Kassambara et al. PLoS One
- Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients
- (2011) F. Magrangeas et al. BLOOD
- Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
- (2011) N. C. Munshi et al. BLOOD
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
- (2011) E. Zamagni et al. BLOOD
- Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival
- (2011) K. D. Boyd et al. CLINICAL CANCER RESEARCH
- The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy
- (2011) Kevin D. Boyd et al. GENES CHROMOSOMES & CANCER
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
- (2011) W-J Chng et al. LEUKEMIA
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- When catastrophe strikes a cell
- (2011) Jose M. C. Tubio et al. NATURE
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
- (2010) H. Avet-Loiseau et al. BLOOD
- Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome
- (2010) N. J. Dickens et al. CLINICAL CANCER RESEARCH
- Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma
- (2010) L. Lode et al. HAEMATOLOGICA
- A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
- (2010) J. Moreaux et al. HAEMATOLOGICA
- Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
- (2010) D. Hose et al. HAEMATOLOGICA
- Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma
- (2010) W J Chng et al. LEUKEMIA
- Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms
- (2010) Sarah K. Brennan et al. PLoS One
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma
- (2009) Julie O'Neal et al. EXPERIMENTAL HEMATOLOGY
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
- (2008) Marta Chesi et al. CANCER CELL
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
- (2008) W. Matsui et al. CANCER RESEARCH
- Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
- (2008) Olivier Decaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and biological significance of RAS mutations in multiple myeloma
- (2008) W J Chng et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More